Anti-AMD Drug Use Stirs Concern In Canada

medpageToday

Intravitreal drug injections for age-related macular degeneration have mushroomed in at least one Canadian province in recent years, likely adding fuel to a controversy over off-label use of bevacizumab (Avastin) for this purpose.

Comments